Inducing Cuproptosis with Copper Ion-Loaded Aloe Emodin Self-Assembled Nanoparticles for Enhanced Tumor Photodynamic Immunotherapy
- PMID: 39998287
- DOI: 10.1002/adhm.202404612
Inducing Cuproptosis with Copper Ion-Loaded Aloe Emodin Self-Assembled Nanoparticles for Enhanced Tumor Photodynamic Immunotherapy
Abstract
Immunotherapy has fundamentally transformed the clinical treatment landscape for non-small cell lung cancer (NSCLC). While its effectiveness is ultimately limited by patient heterogeneity and immunosuppressive tumor microenvironment. Photodynamic therapy (PDT), as an emerging antitumor immunotherapy, has shown its unique therapeutic advantages. However, previous studies often overlooked the potential toxicity of photosensitizers (PS), making the discovery of safe and effective PS a pressing clinical need. In this study, Aloe Emodin (AE), a medicinal plant natural compound, was loaded with copper ions (Cu), and self-assembled into nanoparticles (NPs) under the modification of PEG2k-DSPE-FA. NPs can target, accumulate, and reside within tumor sites, responsively releasing copper ions and AE, thus dual-functioning by inducing tumor cell death via cuproptosis and enhancing PDT effects. The LLC tumor-bearing mouse model demonstrated that NPs induce the maturation of dendritic cells (DCs) in vivo, promote lymphocyte infiltration, transform "cold tumors" into "hot tumors" and significantly enhance the efficacy of immune checkpoint blockade (ICB). This study provides experimental evidence of AE as a clinically promising PDT agent and offers a novel perspective for the synergistic treatment of clinical NSCLC.
Keywords: NSCLC; aloe emodin; cuproptosis; immunogenic cell death; photodynamic therapy.
© 2025 Wiley‐VCH GmbH.
References
-
- H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, CA Cancer J. Clin. 2021, 71, 209.
-
- P. Chen, Y. Liu, Y. Wen, C. Zhou, Cancer Commun. (Lond) 2022, 42, 937.
-
- a) M. Sorin, C. Prosty, L. Ghaleb, K. Nie, K. Katergi, M. H. Shahzad, L. R. Dubé, A. Atallah, A. Swaby, M. Dankner, T. Crump, L. A. Walsh, P. O. Fiset, B. Sepesi, P. M. Forde, T. Cascone, M. Provencio, J. D. Spicer, JAMA Oncol. 2024, 10, 621;
-
- b) Y. Shen, J. Chen, X. P. Li, J. Drug Target 2023, 31, 700.
-
- S. Rossi, A. Farina, A. Malvaso, A. Dinoto, L. Fionda, S. Cornacchini, I. Florean, L. Zuliani, M. Garibaldi, A. Lauletta, F. Baccari, C. Zenesini, R. Rinaldi, S. Mariotto, V. Damato, L. Diamanti, M. Gastaldi, A. Vogrig, E. Marchioni, M. Guarino, Neurol. Neuroimmunol. Neuroinflamm. 2024, 11, e200314.
MeSH terms
Substances
Grants and funding
- 2024ZZTS0286/The Fundamental Research Funds for the Central Universities of Central South University
- CX20240332/Postgraduate Scientific Research Innovation Project of Hunan Province
- 2023JJ50013/Hunan Provincial Natural Science Foundation of China
- 82204531/National Natural Science Foundation of China
- 82474012/National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Medical
